Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

,Paragv Meswani ,Tay Sachs Sandhoff ,Josephine Belluardo ,Guangping Gao ,Gavin Corcoran ,Cynthia Tifft ,Exchange Commission On ,Drug Administration ,Li Weibo Institute For Rare Disease Research ,Sio Gene Therapies Inc ,Nasdaq ,Penelope Booth Rockwell Professor In Biomedical Research ,Exchange Commission ,European Society Of Gene Cell Therapy ,Lifesci Communications ,National Human Genome Research Institute ,Horae Gene Therapy Center ,Virtual Congress ,Umass Chan Medical School ,Gene Therapies ,European Society ,Cell Therapy ,Chief Rd Officer ,Sio Gene ,Deputy Clinical Director ,Principal Investigator ,Floor Mobility ,Webcast Details ,Rare Disease Research ,Viral Vector Core ,Physiological Systems ,Penelope Booth Rockwell Professor ,Biomedical Research ,Chan Medical School ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Private Securities Litigation Reform Act ,Quarterly Report ,Coronavirus Pandemic ,Technology ,Science ,Business ,Health ,Globe Newswire ,Gene Therapy ,